Lifecore Biomedical, Inc. \De\ (LFCR) Net Margin (2010 - 2025)
Lifecore Biomedical, Inc. \De\ (LFCR) posted quarterly Net Margin of 5.62% for Q2 2025, up 1308.0% year-over-year from 0.4% in Q2 2024, and up 87.39% quarter-over-quarter from 44.53% in Q1 2025.
Lifecore Biomedical, Inc. \De\ (LFCR) Net Margin (2010 - 2025) Analysis & Trends
Lifecore Biomedical, Inc. \De\'s Net Margin history runs 16 years deep, the most recent figure standing at 5.62% for Q2 2025.
- In Q2 2025, Net Margin rose 1308.0% year-over-year to 5.62%; the TTM figure through May 2025 stood at 33.08% (down 5228.0% YoY), while the FY2025 annual figure was 34.42%, down 4379.0% from the prior year.
- Net Margin for Q2 2025 stood at 5.62%, up from 44.53% in the prior quarter.
- The five-year high for Net Margin was 47.16% in Q4 2023, with the low at 183.73% in Q2 2022.
- The 5-year median for Net Margin is 17.22% (2022), against an average of 33.72%.
- The sharpest annual moves came in 2022 and 2023: Net Margin slumped 17909 bps in 2022, then soared 17639 bps in 2023.
- Lifecore Biomedical, Inc. \De\'s Net Margin stood at 179.75% in 2021, then soared by 91 bps to 16.49% in 2022, then surged by 386 bps to 47.16% in 2023, then plunged by 157 bps to 26.73% in 2024, then surged by 79 bps to 5.62% in 2025.
- Business Quant data shows LFCR's Net Margin at 5.62% in Q2 2025, 44.53% in Q1 2025, and 26.73% in Q4 2024.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| May 25, 2025 | -5.62% |
| Feb 23, 2025 | -44.53% |
| Nov 24, 2024 | -26.73% |
| Aug 25, 2024 | -65.70% |
| May 26, 2024 | -18.70% |
| Feb 25, 2024 | 43.78% |
| Nov 26, 2023 | 47.16% |
| Aug 27, 2023 | 7.57% |
| May 28, 2023 | -7.34% |
| Feb 26, 2023 | -94.88% |
| Nov 27, 2022 | -16.49% |
| Aug 28, 2022 | -17.95% |
| May 29, 2022 | -183.73% |
| Feb 27, 2022 | -18.60% |
| Nov 28, 2021 | -179.75% |
| Aug 29, 2021 | -5.36% |
| May 30, 2021 | -4.64% |
| Feb 28, 2021 | -15.48% |
| Nov 29, 2020 | -13.59% |
| Aug 30, 2020 | -10.67% |